
### [DOID:0060005](http://purl.obolibrary.org/obo/DOID_0060005)
**Label:** autoimmune disease of endocrine system

**Subclasses:** [DOID:0050167](http://purl.obolibrary.org/obo/DOID_0050167) (autoimmune polyendocrine syndrome type 1), [DOID:12361](http://purl.obolibrary.org/obo/DOID_12361) (Graves' disease), 

**Corr. equiv. classes:** [OMIM:603388](http://purl.obolibrary.org/obo/OMIM_603388), [OMIM:300351](http://purl.obolibrary.org/obo/OMIM_300351), [OMIM:240300](http://purl.obolibrary.org/obo/OMIM_240300), [OMIM:275000](http://purl.obolibrary.org/obo/OMIM_275000), 

**Class expressions from DL-Learner:**

- [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) and [HP:0200028](http://purl.obolibrary.org/obo/HP_0200028) (Pretibial myxedema) 62.50%
- [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) and [HP:0100886](http://purl.obolibrary.org/obo/HP_0100886) (Abnormality of globe location) 62.50%
- [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) and [HP:0100851](http://purl.obolibrary.org/obo/HP_0100851) (Abnormal emotion/affect behavior) 62.50%
- [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) and [HP:0100738](http://purl.obolibrary.org/obo/HP_0100738) (Abnormal eating behavior) 62.50%
- [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0040202](http://purl.obolibrary.org/obo/HP_0040202) (Abnormal consumption behavior) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0025276](http://purl.obolibrary.org/obo/HP_0025276) (Abnormality of skin adnexa physiology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011784](http://purl.obolibrary.org/obo/HP_0011784) (Thyrotoxicosis with diffuse goiter) and [HP:0200028](http://purl.obolibrary.org/obo/HP_0200028) (Pretibial myxedema) 62.50%
- [HP:0011784](http://purl.obolibrary.org/obo/HP_0011784) (Thyrotoxicosis with diffuse goiter) and [HP:0100851](http://purl.obolibrary.org/obo/HP_0100851) (Abnormal emotion/affect behavior) 62.50%


